Thermo Fisher Scientific Inc. (TN8.DE)
EUR 372.55
(-5.86%)
EUR 372.55
(-5.86%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 10.8 Billion USD | -11.62% |
| 2022 | 11.12 Billion USD | -2.06% |
| 2021 | 11.96 Billion USD | 35.95% |
| 2020 | 10.1 Billion USD | 43.48% |
| 2019 | 5.82 Billion EUR | 8.44% |
| 2018 | 5.36 Billion EUR | 21.65% |
| 2017 | 4.41 Billion EUR | 0.83% |
| 2016 | 4.25 Billion EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 2.36 Billion USD | -10.77% |
| 2024 Q2 | 2.98 Billion EUR | 16.24% |
| 2023 FY | - USD | -11.62% |
| 2023 Q4 | 2.56 Billion USD | -4.06% |
| 2023 Q3 | 2.67 Billion USD | 10.66% |
| 2023 Q2 | 2.41 Billion USD | 2.19% |
| 2023 Q1 | 2.36 Billion USD | -10.66% |
| 2022 Q1 | 3.34 Billion EUR | 13.08% |
| 2022 FY | - USD | -2.06% |
| 2022 Q4 | 2.64 Billion USD | -0.03% |
| 2022 Q3 | 2.64 Billion EUR | -0.07% |
| 2022 Q2 | 2.64 Billion EUR | -20.77% |
| 2021 Q4 | 2.95 Billion EUR | 0.0% |
| 2021 FY | - USD | 35.95% |
| 2020 FY | - USD | 43.48% |
| 2019 FY | - EUR | 8.44% |
| 2018 FY | - EUR | 21.65% |
| 2017 FY | - EUR | 0.83% |
| 2016 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| NanoRepro AG | -4.66 Million EUR | 231697.171% |